NovaDel Set To Submit Zolpidem Oral Spray In Second Half 2007
This article was originally published in The Pink Sheet Daily
Executive Summary
Firm also moves up timeline on sumatriptan oral spray submission to first half of 2008.
You may also be interested in...
No Simple Fix For Precipitate Problem; Hana Withdraws Zensana NDA
Hana also drops its SPA request for Marqibo, citing a change in FDA policy on open-label oncology trials.
Latest Imitrex Patent Settlement Protects GSK’s “Authorized” Generic
Dr. Reddy’s sumatriptan generic will likely hit the market several months before Cobalt’s launches in 2009.
Novadel’s NitroMist Application Moves Forward With Complete Response
The nitroglycerin NDA has an updated user fee date in early November.